 | Monte Rosa Therapeutics, Inc. | |||
| NMS : GLUE || Location: United States | ||||
$5.45-0.02 (-0.37%) |
0.13 M | 5.11 - 5.52 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| April 15, 2024 | 1.866 M |
| March 28, 2024 | 1.684 M |
| March 15, 2024 | 1.827 M |
| Feb. 29, 2024 | 1.842 M |
| Feb. 15, 2024 | 1.977 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.34 | -0.58 | -69.89% |
| 09/30/2023 | -0.74 | -0.70 | 5.17% |
| 06/30/2023 | -0.71 | -0.71 | 0.56% |
| 03/31/2023 | -0.69 | -0.65 | 6.16% |
| 12/31/2022 | -0.64 | -0.63 | 0.94% |
GLUE Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 50.154M | Shares Float | 23.646M |
| Short Float | 1.866M | Market Cap | 274.34M |
| Institution ownership | 98.54% | Insider ownership | 0.864% |
| Earnings Date | 05/09/2024 BMO | Cash Per Share | ? |
| Trailing EPS | -2.63 | Forward EPS | -2.26 |